Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_assertion type Assertion NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_head.
- NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_assertion description "[These data suggest that MLL-PTD is a stable marker and can be used as a prognostically important marker of MRD in patients with karyotypically normal AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_provenance.
- NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_assertion evidence source_evidence_literature NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_provenance.
- NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_assertion SIO_000772 15996925 NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_provenance.
- NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_assertion wasDerivedFrom befree-20150227 NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_provenance.
- NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_assertion wasGeneratedBy ECO_0000203 NP559361.RAEekbuPZdBb-P5oKD3T_dFqon54yrDno51MQWCyL1Z9E130_provenance.